Main clinical characteristic of patients with rheumatoid arthritis at baseline and after 24 weeks of infliximab treatment
| Variable | Week 0 | Week 24 | p Value |
|---|---|---|---|
| Values are mean and range or mean (SD). | |||
| CCP, cyclic citrullinated peptide; ESR, erythrocyte sedimentation rate; RF, rheumatoid factor. | |||
| Tender joint count (0–44) | 15 (2 to 44) | 10 (0 to 44) | <0.0001 |
| Swollen joint count (0–44) | 10 (0 to 30) | 4 (0 to 27) | <0.0001 |
| ESR (mm/h) | 42 (18) | 32 (21) | NS |
| C reactive protein (mg/l) | 24 (21) | 18 (28) | NS |
| Anti-CCP (IU) | 107 (9.5) | 92 (9.8) | 0.0001 |
| RF (IU) | 512 (151) | 409 (166) | <0.0001 |